Pacira BioSciences, Inc. (PCRX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 70M 140M 210M Q1 '10: 4.8M Q2 '10: 3.1M Q3 '10: 4.5M Q4 '10: 2.2M Q1 '11: 3.9M Q2 '11: 3.6M Q3 '11: 4M Q4 '11: 4.2M Q1 '12: 7.8M Q2 '12: 12.3M Q3 '12: 8.5M Q4 '12: 10.4M Q1 '13: 11.6M Q2 '13: 17.1M Q3 '13: 23.3M Q4 '13: 33.6M Q1 '14: 36.7M Q2 '14: 47.2M Q3 '14: 52M Q4 '14: 197.7M Q1 '15: 58.3M Q2 '15: 59.1M Q3 '15: 62.2M Q4 '15: 69.3M Q1 '16: 65.5M Q2 '16: 69.6M Q3 '16: 68.4M Q4 '16: 72.9M Q1 '17: 68.4M Q2 '17: 70.1M Q3 '17: 67M Q4 '17: 78.8M Q1 '18: 74.3M Q2 '18: 80.7M Q3 '18: 82.7M Q4 '18: 94.7M Q1 '19: 90.9M Q2 '19: 101.8M Q3 '19: 104.3M Q4 '19: 121.8M Q1 '20: 105.7M Q2 '20: 75.5M Q3 '20: 117.5M Q4 '20: 131M Q1 '21: 119M Q2 '21: 135.6M Q3 '21: 127.7M Q4 '21: 159.2M Q1 '22: 158M Q2 '22: 169.4M Q3 '22: 167.5M Q4 '22: 172M Q1 '23: 160.3M Q2 '23: 169.5M Q3 '23: 163.9M Q4 '23: 181.2M Q1 '24: 167.1M Q2 '24: 178M Q3 '24: 168.6M Q4 '24: 187.3M Q1 '25: 168.9M Q2 '25: 181.1M Q3 '25: 179.5M Q4 '25: 196.9M Q1 '26: 177.4M Q2 '26: 192.4M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

-60M 0 60M 120M 180M Q1 '10: 1M Q2 '10: 206K Q3 '10: 959K Q4 '10: 83K Q1 '11: 196K Q2 '11: 521K Q3 '11: 599K Q4 '11: -2.4M Q1 '12: 1.3M Q2 '12: 5.7M Q3 '12: -801K Q4 '12: 778K Q1 '13: 196K Q2 '13: 6.9M Q3 '13: 8.5M Q4 '13: 15.2M Q1 '14: 18.5M Q2 '14: 27.2M Q3 '14: 31.7M Q4 '14: 120.2M Q1 '15: 40.7M Q2 '15: 40.2M Q3 '15: 46.3M Q4 '15: 49.9M Q1 '16: 45.2M Q2 '16: 46.6M Q3 '16: 25.2M Q4 '16: 49.3M Q1 '17: 43.8M Q2 '17: 46.3M Q3 '17: 48.7M Q4 '17: 57.5M Q1 '18: 51.4M Q2 '18: 59.8M Q3 '18: 63.6M Q4 '18: 70.7M Q1 '19: 63.6M Q2 '19: 76.6M Q3 '19: 82M Q4 '19: 89.9M Q1 '20: 76M Q2 '20: 53.2M Q3 '20: 87.5M Q4 '20: 95.7M Q1 '21: 87.7M Q2 '21: 100.3M Q3 '21: 93.1M Q4 '21: 120.2M Q1 '22: 121.9M Q2 '22: 118.8M Q3 '22: 116.8M Q4 '22: 110M Q1 '23: 111.3M Q2 '23: 121.3M Q3 '23: 124.2M Q4 '23: 133.6M Q1 '24: 119.7M Q2 '24: 133.8M Q3 '24: 129.7M Q4 '24: 147.4M Q1 '25: 134.6M Q2 '25: 140.2M Q3 '25: 145.2M Q4 '25: 156.6M Q1 '26: 141M Q2 '26: 148.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q1 '10: -4.6M Q2 '10: -5.6M Q3 '10: -6.5M Q4 '10: -6M Q1 '11: -7.1M Q2 '11: -8.5M Q3 '11: -8.7M Q4 '11: -14.7M Q1 '12: -11.1M Q2 '12: -6.6M Q3 '12: -15.7M Q4 '12: -15.8M Q1 '13: -18.6M Q2 '13: -12M Q3 '13: -12.8M Q4 '13: -9.8M Q1 '14: -9.3M Q2 '14: -2.8M Q3 '14: -985K Q4 '14: -5.2M Q1 '15: 3.3M Q2 '15: 1.8M Q3 '15: 5.1M Q1 '16: -2.3M Q2 '16: -6.4M Q3 '16: -20.9M Q4 '16: -2.5M Q1 '17: -14.1M Q2 '17: -15.8M Q3 '17: -3.6M Q4 '17: 8.5M Q1 '18: -6.9M Q2 '18: 6.5M Q3 '18: 4M Q4 '18: 12.3M Q1 '19: 1.1M Q2 '19: 5.3M Q3 '19: 2.4M Q4 '19: 1.7M Q1 '20: 17.1M Q2 '20: -7.1M Q3 '20: 17.6M Q4 '20: 18.8M Q1 '21: 19.4M Q2 '21: 34.8M Q3 '21: 31.4M Q4 '21: 4.2M Q1 '22: 17.4M Q2 '22: 31.2M Q3 '22: 21.3M Q1 '23: -3.1M Q2 '23: 39.9M Q3 '23: 17.7M Q4 '23: 33.2M Q1 '24: 13.2M Q2 '24: 28.2M Q3 '24: -139.5M Q4 '24: 24.7M Q1 '25: 2M Q2 '25: 8.5M Q3 '25: 6.4M Q4 '25: 2.3M Q1 '26: 6.9M Q2 '26: 4.3M Q4 '11 Q4 '13 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q2 '24 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q1 '10: -5.4M Q2 '10: -6.8M Q3 '10: -7.9M Q4 '10: -7M Q1 '11: -9.8M Q2 '11: -8.8M Q3 '11: -9.5M Q4 '11: -15.3M Q1 '12: -11.9M Q2 '12: -8.3M Q3 '12: -15.7M Q4 '12: -16.3M Q1 '13: -23.1M Q2 '13: -14M Q3 '13: -14.8M Q4 '13: -12M Q1 '14: -11.5M Q2 '14: -5M Q3 '14: -3M Q4 '14: -13.7M Q1 '15: 1.3M Q2 '15: 8K Q3 '15: 3.1M Q4 '15: -2.5M Q1 '16: -3.9M Q2 '16: -8M Q3 '16: -22.2M Q4 '16: -4M Q1 '17: -19.9M Q2 '17: -19.7M Q3 '17: -7.6M Q4 '17: 4.6M Q1 '18: -10.7M Q2 '18: 2.6M Q3 '18: -640K Q4 '18: 8.3M Q1 '19: -2.8M Q2 '19: 2.7M Q3 '19: -6.1M Q4 '19: -4.9M Q1 '20: 8.2M Q2 '20: -7.3M Q3 '20: 130.1M Q4 '20: 14.5M Q1 '21: 10.4M Q2 '21: 19.1M Q3 '21: 17.7M Q1 '22: 6.8M Q2 '22: 19.9M Q3 '22: -693K Q4 '22: -10.1M Q1 '23: -19.5M Q2 '23: 25.8M Q3 '23: 10.9M Q4 '23: 24.9M Q1 '24: 9M Q2 '24: 18.9M Q3 '24: -143.5M Q4 '24: 16M Q1 '25: 4.8M Q2 '25: -4.8M Q3 '25: 5.4M Q4 '25: 1.6M Q1 '26: 2.9M Q2 '26: 4.7M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 30M 60M 90M Q1 '10: 3.7M Q2 '10: 2.8M Q3 '10: 3.6M Q4 '10: 2.1M Q1 '11: 3.7M Q2 '11: 3.1M Q3 '11: 3.4M Q4 '11: 6.6M Q1 '12: 6.5M Q2 '12: 6.7M Q3 '12: 9.3M Q4 '12: 9.7M Q1 '13: 11.4M Q2 '13: 10.2M Q3 '13: 14.8M Q4 '13: 18.4M Q1 '14: 18.1M Q2 '14: 20M Q3 '14: 20.4M Q4 '14: 77.4M Q1 '15: 17.6M Q2 '15: 18.9M Q3 '15: 15.9M Q4 '15: 19.4M Q1 '16: 20.3M Q2 '16: 23.1M Q3 '16: 43.2M Q4 '16: 23.6M Q1 '17: 24.6M Q2 '17: 23.8M Q3 '17: 18.2M Q4 '17: 21.3M Q1 '18: 22.9M Q2 '18: 20.9M Q3 '18: 19.1M Q4 '18: 24M Q1 '19: 27.3M Q2 '19: 25.2M Q3 '19: 22.3M Q4 '19: 31.9M Q1 '20: 29.7M Q2 '20: 22.3M Q3 '20: 30M Q4 '20: 35.3M Q1 '21: 31.3M Q2 '21: 35.2M Q3 '21: 34.7M Q4 '21: 39M Q1 '22: 36.1M Q2 '22: 50.6M Q3 '22: 50.7M Q4 '22: 61.9M Q1 '23: 49M Q2 '23: 48.2M Q3 '23: 39.8M Q4 '23: 47.7M Q1 '24: 47.4M Q2 '24: 44.3M Q3 '24: 38.9M Q4 '24: 39.9M Q1 '25: 34.3M Q2 '25: 40.9M Q3 '25: 34.3M Q4 '25: 40.3M Q1 '26: 36.4M Q2 '26: 44.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Cash Flow Quarterly

-25M 0 25M 50M 75M Q4 '10: -5.8M Q1 '11: -4M Q2 '11: -10.9M Q3 '11: -8.5M Q4 '11: -7.6M Q1 '12: -17.5M Q2 '12: -20.2M Q3 '12: -11.2M Q4 '12: -21.2M Q1 '13: -13.8M Q2 '13: -13.3M Q3 '13: -9.8M Q4 '13: -6.9M Q1 '14: -4.7M Q2 '14: 8.2M Q3 '14: 8.4M Q4 '14: 26.6M Q1 '15: -870K Q2 '15: 7.2M Q3 '15: 4.7M Q4 '15: 17M Q1 '16: -3.1M Q2 '16: 7.5M Q3 '16: 11.7M Q4 '16: 17.3M Q1 '17: 6K Q2 '17: 3.7M Q3 '17: -2.8M Q4 '17: 16.9M Q1 '18: -2.7M Q2 '18: 13.7M Q3 '18: 16.6M Q4 '18: 21.2M Q1 '19: 3.5M Q2 '19: 22.8M Q3 '19: 18.4M Q4 '19: 25.9M Q1 '20: 6.2M Q2 '20: -15.6M Q3 '20: 39.8M Q4 '20: 46.7M Q1 '21: 12.1M Q2 '21: 30.1M Q3 '21: 60.3M Q4 '21: 23.2M Q1 '22: 30.8M Q2 '22: 29.8M Q3 '22: 42.7M Q4 '22: 42M Q1 '23: 19.1M Q2 '23: 43.5M Q3 '23: 44.4M Q4 '23: 47.6M Q1 '24: 49.1M Q2 '24: 53.2M Q3 '24: 53.9M Q4 '24: 33.1M Q1 '25: 35.5M Q2 '25: 12M Q3 '25: 60.8M Q4 '25: 43.7M Q1 '26: 25.7M Q2 '26: 57.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-40M -20M 0 20M 40M 60M Q4 '10: -8.8M Q1 '11: -4.8M Q2 '11: -12.1M Q3 '11: -10.1M Q4 '11: -10.1M Q1 '12: -20.4M Q2 '12: -24.6M Q3 '12: -17.4M Q4 '12: -25.9M Q1 '13: -16.7M Q2 '13: -15.1M Q3 '13: -14.5M Q4 '13: -9.7M Q1 '14: -8.5M Q2 '14: 2.2M Q3 '14: 4M Q4 '14: 3.6M Q1 '15: -8.7M Q2 '15: -4.7M Q3 '15: -6.8M Q4 '15: 7.9M Q1 '16: -10.2M Q2 '16: -1.3M Q3 '16: 7.8M Q4 '16: 12.5M Q1 '17: -3.6M Q2 '17: -1.5M Q3 '17: -8.2M Q4 '17: 11.9M Q1 '18: -7.9M Q2 '18: 11.1M Q3 '18: 12.2M Q4 '18: 19M Q1 '19: 1.5M Q2 '19: 20.7M Q3 '19: 16.8M Q4 '19: 21.4M Q1 '20: -516K Q2 '20: -24.5M Q3 '20: 32M Q4 '20: 32.3M Q1 '21: -992K Q2 '21: 19.6M Q3 '21: 47.2M Q4 '21: 14M Q1 '22: 23.1M Q2 '22: 18.1M Q3 '22: 37.5M Q4 '22: 36.5M Q1 '23: 12.6M Q2 '23: 40.1M Q3 '23: 41M Q4 '23: 45.8M Q1 '24: 46.3M Q2 '24: 51.6M Q3 '24: 49.8M Q4 '24: 31M Q1 '25: 26.9M Q2 '25: 9.3M Q3 '25: 57M Q4 '25: 43.5M Q1 '26: 23M Q2 '26: 56.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '10: 573.5K Q1 '11: 10M Q2 '11: 17.2M Q3 '11: 17.2M Q1 '12: 25.4M Q2 '12: 31M Q3 '12: 32.4M Q1 '13: 32.7M Q2 '13: 33.1M Q3 '13: 33.4M Q1 '14: 33.7M Q2 '14: 35.5M Q3 '14: 35.9M Q4 '14: 35.3M Q1 '15: 41.8M Q2 '15: 41.4M Q3 '15: 41M Q1 '16: 37M Q2 '16: 37.2M Q3 '16: 37.3M Q1 '17: 38M Q2 '17: 40.2M Q3 '17: 40.5M Q1 '18: 40.7M Q2 '18: 41.7M Q3 '18: 41M Q1 '19: 41.2M Q2 '19: 42.3M Q3 '19: 41.6M Q1 '20: 42.8M Q2 '20: 42.2M Q3 '20: 44.3M Q1 '21: 46M Q2 '21: 45.6M Q3 '21: 45.5M Q1 '22: 46.4M Q2 '22: 52.5M Q3 '22: 45.8M Q1 '23: 45.9M Q2 '23: 52.1M Q3 '23: 52.1M Q1 '24: 52.2M Q2 '24: 50.5M Q3 '24: 46.1M Q1 '25: 46.5M Q2 '25: 45.5M Q3 '25: 44.5M Q1 '26: 40.9M Q2 '26: 40.3M Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '10: -47.29 Q1 '11: -38.88 Q2 '11: -27.53 Q3 '11: -14.31 Q4 '11: -2.79 Q1 '12: -2.28 Q2 '12: -2.04 Q3 '12: -1.98 Q4 '12: -1.73 Q1 '13: -1.97 Q2 '13: -2.12 Q3 '13: -2.07 Q4 '13: -1.93 Q1 '14: -1.56 Q2 '14: -1.28 Q3 '14: -0.92 Q4 '14: -0.95 Q1 '15: -0.58 Q2 '15: -0.44 Q3 '15: -0.28 Q4 '15: 0.04 Q1 '16: -0.09 Q2 '16: -0.30 Q3 '16: -0.97 Q4 '16: -1.01 Q1 '17: -1.43 Q2 '17: -1.71 Q3 '17: -1.31 Q4 '17: -1.09 Q1 '18: -0.83 Q2 '18: -0.28 Q3 '18: -0.11 Q4 '18: -0.02 Q1 '19: 0.17 Q2 '19: 0.17 Q3 '19: 0.04 Q4 '19: -0.28 Q1 '20: -0.02 Q2 '20: -0.25 Q3 '20: 2.84 Q4 '20: 3.28 Q1 '21: 3.32 Q2 '21: 3.91 Q3 '21: 1.36 Q4 '22: 0.34 Q1 '23: -0.24 Q2 '23: -0.13 Q3 '23: 0.12 Q4 '23: 0.83 Q1 '24: 1.45 Q2 '24: 1.33 Q3 '24: -2.01 Q4 '24: -2.15 Q1 '25: -2.24 Q2 '25: -2.74 Q3 '25: 0.49 Q4 '25: 0.15 Q1 '26: 0.12 Q2 '26: 0.35 Q2 '11 Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.